Blood Cancer Infographic - Bristol Myers Squibb
Blood Cancers
Blood cancers, or hematologic cancers, a?ect the production and function of blood cells.
These cancers typically begin in the bone marrow where blood is produced.
What are Blood Cancers?
Estimated Global Incidence
An estimated 1.24 million blood cancer cases occur annually
worldwide, accounting for approximately 6% of all cancer cases.
Blood cancers, like all cancers, are characterized by the
overproduction of an abnormal type of cell.
Lymphoma
Blood cancer cells do not form solid tumors, but their
out-of-control growth crowds out normal cells in the blood, bone
marrow or plasma, preventing normal cells from developing and
performing important functions.
615,993
Leukemia
454,341
Multiple Myeloma
There are 3 main types of blood cancers:
168,765
LEUKEMIA. Cancers located in the blood and bone
marrow due to the overproduction of abnormal
white blood cells
1.24 million
LYMPHOMA. A group of blood cancers that develop
in the lymphatic system
Global Mortality
Worldwide, approximately
720,000
MULTIPLE MYELOMA. Cancer formed by malignant
plasma cells, typically originating in the bone marrow
Other bone marrow
disorders that are
also considered
blood cancers, but
fall outside of these
types, include:
Myelodysplastic Syndromes
(MDS). Occur when mutations
prevent the bone marrow
from properly making blood
stem cells that form healthy
blood cells
Myeloproliferative
Neoplasms (MPN).
Occur when the
body overproduces
white or red blood
cells, or platelets
Symptoms
Symptoms of di?erent blood cancers vary. Some cancers elicit
pronounced symptoms, while the symptoms of others can go
unnoticed or be mistaken for symptoms of something less
severe, like loss of appetite or persistent fatigue.
Loss of
appetite
Total blood
cancer cases
people die from blood cancer
every year, accounting for more
than 7% of cancer deaths.
SOURCE: GLOBOCAN 2018
Risk Factors
Di?erent types of blood cancers have di?erent risk
factors. While risk factors for some cancers can be
controlled or prevented, most identi?ed risk factors for
blood cancers cannot, like age, race or gender.
Persistent
fatigue
Age
Race
Gender
Refer to our disease-speci?c infographic library to learn more about multiple myeloma, MDS, myelo?brosis and several di?erent types of leukemia and lymphoma.
Treatment Options
Survival rates for most hematologic
malignancies have improved over
time, likely due to the introduction
of new and more e?ective
treatments, which can include:
Chemotherapy
Radiation
Targeted
therapy
Stem cell
transplant
Immunotherapy
Gene or
cell therapy
? 2020 Bristol Myers Squibb
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- older adults with blood cancers how they fare
- special section rare cancers in adults
- a list of rare cancer
- special section rare cancers in adults american cancer society
- understanding 5 blood cancer blood cancer leaders lls
- types of cancers that develop in young adults american cancer society
- blood cancer find raises new treatment hopes
- blood cancer infographic bristol myers squibb
- survival from rare cancer in adults a population based study
- call to action rare cancers in all policies rare cancers europe 28 9 21
Related searches
- blood pressure medicine cancer risk
- blood pressure cancer meds
- cancer and low blood pressure
- cancer and high blood pressure
- lung cancer high blood pressure
- high blood pressure cancer symptom
- blood pressure cancer risk
- bristol historical society bristol pa
- low blood pressure cancer patients
- blood cancer types
- new prostate cancer blood test
- blood pressure medicine cancer recall